A168330 Stock Overview
Naturalendo Tech Co., Ltd. engages in the research, development, manufacturing, and sale of physical chemistry and biology, biological agents, food additives, and health functional food in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Naturalendo Tech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,620.00 |
| 52 Week High | ₩3,100.00 |
| 52 Week Low | ₩1,896.00 |
| Beta | 0.20 |
| 1 Month Change | 8.26% |
| 3 Month Change | 17.75% |
| 1 Year Change | -9.66% |
| 3 Year Change | n/a |
| 5 Year Change | -66.06% |
| Change since IPO | -88.86% |
Recent News & Updates
Shareholder Returns
| A168330 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 1.2% | 2.4% | 0.6% |
| 1Y | -9.7% | 11.1% | 6.9% |
Return vs Industry: A168330 underperformed the KR Biotechs industry which returned 11.1% over the past year.
Return vs Market: A168330 underperformed the KR Market which returned 6.9% over the past year.
Price Volatility
| A168330 volatility | |
|---|---|
| A168330 Average Weekly Movement | 4.7% |
| Biotechs Industry Average Movement | 8.0% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A168330 has not had significant price volatility in the past 3 months.
Volatility Over Time: A168330's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 71 | Heedo Kim | www.naturalendo.co.kr |
Naturalendo Tech Co., Ltd. engages in the research, development, manufacturing, and sale of physical chemistry and biology, biological agents, food additives, and health functional food in South Korea. The company offers vegetable female hormones, Wellmune immune booster, transdermal drug delivery system, microneedles, Derma A2 for the treatment of atopic dermatitis and acne, and other hormone-related materials. Naturalendo Tech Co., Ltd.
Naturalendo Tech Co., Ltd. Fundamentals Summary
| A168330 fundamental statistics | |
|---|---|
| Market cap | ₩82.72b |
| Earnings (TTM) | -₩4.37b |
| Revenue (TTM) | ₩18.79b |
4.4x
P/S Ratio-18.9x
P/E RatioIs A168330 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A168330 income statement (TTM) | |
|---|---|
| Revenue | ₩18.79b |
| Cost of Revenue | ₩12.91b |
| Gross Profit | ₩5.88b |
| Other Expenses | ₩10.25b |
| Earnings | -₩4.37b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -138.35 |
| Gross Margin | 31.28% |
| Net Profit Margin | -23.25% |
| Debt/Equity Ratio | 7.3% |
How did A168330 perform over the long term?
See historical performance and comparison